Marta Kubera
Impact in
- Biological Psychiatry top 0.01%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 0.5%
- Stress Responses and Cortisol
Papers in
-
- Tryptophan and brain disorders 42
-
- Stress Responses and Cortisol 29
- Co-authors
- Michael H. J. Maes (79 shared papers)Agnieszka Basta‐Kaim (102 shared papers)Jean–Claude Leunis (9 shared papers)Bogusława Budziszewska (77 shared papers)Władysław Lasoń (80 shared papers)Eugène Bosmans (15 shared papers)Monika Leśkiewicz (52 shared papers)Joanna Brzeszcz (2 shared papers)
In The Last Decade
Marta Kubera
179 papers receiving 9.8k citations
Marta Kubera's Hit Papers
Peers
Comparison fields: 5 of 103
- Biological Psychiatry 2.1k
- Behavioral Neuroscience 406
- Pharmacology 666
- Psychiatry and Mental health 917
- Neurology 231
Countries citing papers authored by Marta Kubera
This map shows the geographic impact of Marta Kubera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Kubera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Kubera more than expected).
Fields of papers citing papers by Marta Kubera
This network shows the impact of papers produced by Marta Kubera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Kubera. The network helps show where Marta Kubera may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Kubera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Hit paper breakdown → | 2008 | 771 |
| 2 | The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression Hit paper breakdown → | 2010 | 594 |
| 3 | The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Hit paper breakdown → | 2008 | 509 |
| 4 | 2010 | 393 | |
| 5 | Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut Hit paper breakdown → | 2012 | 383 |
| 6 | 2001 | 308 | |
| 7 | 2008 | 282 | |
| 8 | 2016 | 279 | |
| 9 | Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. | 2011 | 276 |
| 10 | 2012 | 182 | |
| 11 | 2010 | 150 | |
| 12 | 2011 | 149 | |
| 13 | 2005 | 137 | |
| 14 | Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. | 2009 | 137 |
| 15 | Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome. | 2009 | 137 |
| 16 | 2011 | 132 | |
| 17 | 2019 | 129 | |
| 18 | 2010 | 128 | |
| 19 | 2014 | 124 | |
| 20 | Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. | 2009 | 123 |
About Marta Kubera
Marta Kubera is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Psychiatry and Mental health, Immunology and Pharmacology, having authored 180 papers that have together received 10.2k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (42 papers), Stress Responses and Cortisol (29 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (12 papers), Immunotoxicology and immune responses (9 papers), Cancer, Stress, Anesthesia, and Immune Response (7 papers), Treatment of Major Depression (6 papers), Epilepsy research and treatment (5 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Biological Psychiatry (2.1k citations), Behavioral Neuroscience (406 citations), Pharmacology (666 citations), Psychiatry and Mental health (917 citations) and Neurology (231 citations). Marta Kubera has collaborated with scholars based in Poland, Australia and Thailand. Frequent co-authors include Michael H. J. Maes, Agnieszka Basta‐Kaim, Jean–Claude Leunis, Bogusława Budziszewska, Władysław Lasoń, Eugène Bosmans, Monika Leśkiewicz, Joanna Brzeszcz, Lisa E. Goehler and Günter Kenis. Their work appears in journals such as Pharmacological Reports, Journal of Affective Disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, International Immunopharmacology and Psychoneuroendocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.